DENTSPLY SIRONA (NASDAQ:XRAY) vs. Orthofix International N.V. (OFIX) Head to Head Comparison

Orthofix International N.V. (NASDAQ: OFIX) and DENTSPLY SIRONA (NASDAQ:XRAY) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk.

Volatility and Risk

Orthofix International N.V. has a beta of 0.2, suggesting that its stock price is 80% less volatile than the S&P 500. Comparatively, DENTSPLY SIRONA has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500.

Valuation & Earnings

This table compares Orthofix International N.V. and DENTSPLY SIRONA’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Orthofix International N.V. $418.71 million 2.14 $45.74 million $0.42 117.60
DENTSPLY SIRONA $3.84 billion 3.67 $823.80 million ($3.47) -17.68

DENTSPLY SIRONA has higher revenue and earnings than Orthofix International N.V.. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Orthofix International N.V., indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Orthofix International N.V. and DENTSPLY SIRONA, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orthofix International N.V. 0 0 5 0 3.00
DENTSPLY SIRONA 1 2 6 0 2.56

Orthofix International N.V. presently has a consensus target price of $52.50, indicating a potential upside of 6.30%. DENTSPLY SIRONA has a consensus target price of $65.63, indicating a potential upside of 6.97%. Given DENTSPLY SIRONA’s higher probable upside, analysts clearly believe DENTSPLY SIRONA is more favorable than Orthofix International N.V..


DENTSPLY SIRONA pays an annual dividend of $0.35 per share and has a dividend yield of 0.6%. Orthofix International N.V. does not pay a dividend. DENTSPLY SIRONA pays out -10.1% of its earnings in the form of a dividend.

Insider & Institutional Ownership

95.8% of Orthofix International N.V. shares are owned by institutional investors. Comparatively, 93.9% of DENTSPLY SIRONA shares are owned by institutional investors. 5.6% of Orthofix International N.V. shares are owned by company insiders. Comparatively, 2.0% of DENTSPLY SIRONA shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.


This table compares Orthofix International N.V. and DENTSPLY SIRONA’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Orthofix International N.V. 1.88% 9.96% 7.32%
DENTSPLY SIRONA -20.57% 7.24% 5.02%

Orthofix International N.V. Company Profile

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim. The Biologics products include AlloQuent Structural Allografts, Trinity ELITE, Trinity Evolution and VersaShield. The Extremity Fixation products include Fixator, Eight-Plate Guided Growth System and Contours VPS Volar Plating System III. The Spine Fixation products include Hallmark Anterior Cervical Plate System, Ascent LE Posterior Occipital Cervico-Thoracic (POCT) System, Firebird Deformity Correction System, Phoenix Minimally Invasive Spinal Fixation System, Samba-Screw System, LONESTAR Cervical Stand Alone (CSA), SKYHAWK Lateral Interbody Fusion System & Lateral Plate System and CENTURION POCT System.


DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies. The dental industry encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Its principal dental product categories are dental consumable products, dental laboratory products, dental specialty products and dental equipment. Additionally, its consumable medical device products are used for urological and surgical applications. These products are produced by the Company in the United States and internationally and are distributed throughout the world under various brand names, including ANKYLOS, AQUASIL ULTRA, ARTICADENT, ATLANTIS, CALIBRA, CAULK, CAVITRON, CELTRA, DELTON, DENTSPLY, DETREY and DYRACT.

Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with's FREE daily email newsletter.

Leave a Reply